Kennard M L, Richardson D R, Gabathuler R, Ponka P, Jefferies W A
Biotechnology Laboratory, University of British Columbia, Vancouver, Canada.
EMBO J. 1995 Sep 1;14(17):4178-86. doi: 10.1002/j.1460-2075.1995.tb00091.x.
The established process for iron uptake into mammalian cells involves transferrin and its receptor. Here, the role of the glycosyl-phosphatidylinositol (GPI)-linked transferrin homologue, melanotransferrin or p97, was studied using CHO cell lines defective in the transferrin receptor (TR) and transfected with human TR and/or human p97. The presence of p97 doubled the iron uptake, which could be explained by the binding of one atom of iron to one molecule of p97. The internalization of iron was shown to be temperature sensitive and saturated at a media iron concentration of 2.5 micrograms/ml with a Vmax of 0.1 pmol Fe/10(6) cell/min and a Km of 2.58 microM for p97. Treatment of the cells with either phosphatidylinositol-phospholipase C or monoclonal antibodies against p97 resulted in over a 50% reduction and a 47% increase in the iron uptake respectively. These data identify p97 as a unique cell surface GPI-anchored, iron binding protein involved in the transferrin-independent uptake of iron in mammals.
哺乳动物细胞摄取铁的既定过程涉及转铁蛋白及其受体。在此,利用转铁蛋白受体(TR)缺陷且转染了人TR和/或人p97的CHO细胞系,研究了糖基磷脂酰肌醇(GPI)连接的转铁蛋白同源物黑素转铁蛋白或p97的作用。p97的存在使铁摄取量增加了一倍,这可以通过一个铁原子与一个p97分子的结合来解释。铁的内化显示对温度敏感,在培养基铁浓度为2.5微克/毫升时达到饱和,p97的Vmax为0.1皮摩尔铁/10⁶个细胞/分钟,Km为2.58微摩尔。用磷脂酰肌醇磷脂酶C或抗p97单克隆抗体处理细胞,分别导致铁摄取量减少超过50%和增加47%。这些数据表明p97是一种独特的细胞表面GPI锚定的铁结合蛋白,参与哺乳动物中不依赖转铁蛋白的铁摄取。